Literature DB >> 7872182

Angiographic predictors of new coronary occlusions.

M K Pétursson1, E H Jónmundsson, A Brekkan, T Hardarson.   

Abstract

To determine whether coronary angiography is predictive of the future site of coronary occlusion, we analyzed the coronary angiograms of 246 consecutive patients having two or more angiograms without therapeutic invasive intervention in the interval between angiograms. The average interval between studies was 46 months. Of 2183 normal segments at the first angiogram, 51 (2.3%) were occluded at the second angiogram, whereas in segments with minimal disease (1% to 25% diameter stenosis) 33 (8%) of 411 were occluded (p < 0.05). There was a further stepwise increase in the occlusion ratio, with increasing stenosis reaching a 31% occlusion ratio in lesions with critical (91% to 99%) stenosis at the first angiogram. For any given degree of stenosis, the occlusion ratio of "long" lesions (5 to 20 mm) was on the average more than twice that of "short" lesions (< 5 mm, p < 0.01), except in lesions with critical stenosis (91% to 99%) where length was no longer important. Occlusion of segments judged free of disease on the first angiogram was highest in the right coronary artery, 4.7%, versus 2.7% in the left anterior descending and 0.6% in the circumflex artery (p < 0.01). History of recent myocardial infarction was a good clinical predictor of occlusion and deterioration of ventricular function.

Entities:  

Mesh:

Year:  1995        PMID: 7872182     DOI: 10.1016/0002-8703(95)90279-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  A fuzzy classification system to predict renal artery restenosis after angioplasty.

Authors:  I Cherrak; M C Jaulent; P Degoulet
Journal:  Proc AMIA Symp       Date:  1998

Review 2.  [Rationale for lipid therapy. Prevention or treatment of coronary heart disease?].

Authors:  E Windler; F U Beil
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.